LC
PFE icon

Lincoln Capital’s Pfizer PFE Stock Holding History

Lincoln Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Hold
9,854
– – 0.04% 128
2026
Q1 		$277K Sell
9,854
-370
-4% -$9.85K 0.05% 116
2025
Q4 		$255K Sell
10,224
-47
-0.5% -$1.19K 0.05% 117
2025
Q3 		$281K Sell
10,271
-724
-7% -$17.9K 0.05% 111
2025
Q2 		$267K Sell
10,995
-1,992
-15% -$46.5K 0.05% 114
2025
Q1 		$293K Sell
12,987
-300
-2% -$7.85K 0.06% 104
2024
Q4 		$353K Sell
13,287
-304
-2% -$8.25K 0.07% 91
2024
Q3 		$393K Sell
13,591
-68
-0.5% -$1.98K 0.08% 86
2024
Q2 		$382K Buy
13,659
+1,100
+9% +$30.3K 0.09% 84
2024
Q1 		$349K Hold
12,559
– – 0.08% 86
2023
Q4 		$362K Hold
12,559
– – 0.09% 81
2023
Q3 		$417K Buy
12,559
+570
+5% +$20.2K 0.11% 75
2023
Q2 		$440K Hold
11,989
– – 0.11% 76
2023
Q1 		$489K Sell
11,989
-292
-2% -$12.6K 0.13% 74
2022
Q4 		$629K Sell
12,281
-93
-0.8% -$4.46K 0.18% 65
2022
Q3 		$541K Sell
12,374
-7,276
-37% -$354K 0.17% 66
2022
Q2 		$1.03M Hold
19,650
– – 0.29% 46
2022
Q1 		$1.02M Sell
19,650
-550
-3% -$28.5K 0.24% 50
2021
Q4 		$1.19M Buy
20,200
+170
+0.8% +$8.42K 0.3% 42
2021
Q3 		$861K Buy
20,030
+7,200
+56% +$319K 0.23% 50
2021
Q2 		$502K Buy
12,830
+1,878
+17% +$73K 0.14% 62
2021
Q1 		$397K Sell
10,952
-690
-6% -$24.5K 0.12% 66
2020
Q4 		$429K Sell
11,642
-49
-0.4% -$1.8K 0.14% 62
2020
Q3 		$407K Buy
11,691
+534
+5% +$18.7K 0.15% 57
2020
Q2 		$346K Hold
11,157
– – 0.14% 60
2020
Q1 		$345K Hold
11,157
– – 0.17% 54
2019
Q4 		$415K Hold
11,157
– – 0.17% 54
2019
Q3 		$380K Sell
11,157
-202
-2% -$7.34K 0.17% 54
2019
Q2 		$467K Sell
11,359
-211
-2% -$8.38K 0.21% 49
2019
Q1 		$466K Sell
11,570
-342
-3% -$13.7K 0.23% 46
2018
Q4 		$493K Hold
11,912
– – 0.27% 40
2018
Q3 		$498K Buy
11,912
+141
+1% +$5.43K 0.25% 42
2018
Q2 		$415K Sell
11,771
-396
-3% -$13.5K 0.22% 46
2018
Q1 		$410K Buy
12,167
+87
+0.7% +$2.99K 0.22% 46
2017
Q4 		$415K Buy
12,080
+369
+3% +$12.6K 0.23% 45
2017
Q3 		$397K Sell
11,711
-506
-4% -$16.3K 0.25% 41
2017
Q2 		$389K Buy
12,217
+585
+5% +$18.4K 0.24% 42
2017
Q1 		$378K Buy
11,632
+2,256
+24% +$71.1K 0.26% 42
2016
Q4 		$289K Buy
9,376
+344
+4% +$10.5K 0.21% 47
2016
Q3 		$290K Buy
9,032
+133
+1% +$4.45K 0.21% 44
2016
Q2 		$297K Buy
8,899
+99
+1% +$3.16K 0.22% 43
2016
Q1 		$247K Buy
8,800
+35
+0.4% +$1K 0.19% 49
2015
Q4 		$268K Buy
8,765
+470
+6% +$14.8K 0.21% 44
2015
Q3 		$247K Buy
8,295
+119
+1% +$3.82K 0.2% 43
2015
Q2 		$260K Buy
8,176
+390
+5% +$12.7K 0.22% 44
2015
Q1 		$257K Sell
7,786
-118
-1% -$3.75K 0.22% 46
2014
Q4 		$234K Buy
+7,904
New +$227K 0.2% 50

Other funds holding PFE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Lincoln Capital's PFE Position: Q2 2026 in Review

Lincoln Capital held its Pfizer (PFE) position steady in Q2 2026 at 9,854 shares worth $237K. The position accounts for 0.04% of the portfolio, ranked #128.

Lincoln Capital first reported a position in PFE in Q4 2014 and has held it in 47 quarters since. The position peaked at $1.19M in Q4 2021. 1,596 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Lincoln Capital held 9,854 shares of Pfizer worth $237K as of Q2 2026.
  • Lincoln Capital left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.04% of Lincoln Capital's portfolio in Q2 2026, its #128 holding.
  • Lincoln Capital first reported a position in Pfizer in Q4 2014 and has held it in 47 quarters since.
  • Lincoln Capital's Pfizer position peaked at $1.19M in Q4 2021.
  • 1,596 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Lincoln Capital's 13F filing for Q2 2026, filed 7 Jul 2026.